Myeloid Malignancy-Related Gene Mutation Screening: A panel of 67 genes associated with the diagnosis, treatment, prognosis, and recurrence of myeloid malignancies (including KIT, SRSF2, TET2, and ASXL2) was analyzed, with no relevant mutations identified. This evidence concerns the gene SRSF2 and myeloid neoplasm.